ArticleVeterinary ophthalmology2026
A Pilot Investigation of Transforming Growth Factor-β2 and Total Protein Concentrations in Aqueous Humor of Canine Glaucomatous Eyes With and Without Ahmed Glaucoma Valve Surgery.
Article in Veterinary ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo investigate responses to surgical interventions in concentrations of transforming growth factor-β2 (TGF-β2) and total protein (TP) in the aqueous humor (AH) of primary angle-closure glaucoma (PACG) eyes, with and without Ahmed glaucoma valve surgery in dogs. ANIMAL STUDIED: Nineteen eyes diagnosed with PACG from client-owned dogs and nine non-glaucomatous eyes from both client-owned dogs and research Beagles. PROCEDURES: AH samples were collected and analyzed for TP and TGF-β2 via bicinchoninic acid assay and an enzyme-linked immunosorbent assay. The samples included AH from pre-surgical eyes that had aqueous paracentesis for intraocular pressure (IOP) management (pre-surgical group; n = 6) and from post-surgical eyes when tissue plasminogen activator was injected (post-surgery group; n = 7); fluid aspirated from blebs during surgical revision (bleb group; n = 6), and normal control AH samples from both client-owned dogs undergoing ocular surgery for non-glaucomatous conditions and research Beagles (control group; n = 9).
resultsTP and TGF-β2 concentrations were significantly higher in all PACG groups compared to normal AH (p < 0.01). Bleb fluid exhibited the highest TP and TGF-β2 concentrations among glaucomatous groups. Post-surgical AH had significantly lower TGF-β2 concentrations than both pre-surgical and bleb fluid (p = 0.0168, p = 0.0023, respectively). No significant correlation was found between IOP and either TP or TGF-β2 in any group (p > 0.05).
conclusionsElevated TGF-β2 in PACG could contribute to disease progression and post-surgical fibrosis. These findings support future studies to examine the potential of TGF-β2 modulation as a therapeutic approach to improving long-term surgical outcomes following Ahmed glaucoma valve surgery in canine PACG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.